Samuel G Rayner
Overview
Explore the profile of Samuel G Rayner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
224
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leary P, Le R, Panjabi S, Hartney J, Goyal A, Ward C, et al.
Am J Respir Crit Care Med
. 2025 Jan;
PMID: 39836217
Rationale: Guidelines recommend patients with pulmonary arterial hypertension (PAH) be referred to pulmonary hypertension (PH) centers, but little is known about where care is actually delivered in the United States...
2.
Leary P, Rayner S, Branch K, Hogl L, Liston N, Barros L, et al.
Chest
. 2025 Jan;
PMID: 39761829
Background: Adaptation of the right ventricle is a key determinant of outcomes in pulmonary arterial hypertension (PAH). Despite a compelling rationale to develop targeted therapies for the right ventricle in...
3.
Pi H, Xia L, Boucherat O, Suresh K, Hemnes A, Bonnet S, et al.
Circ Heart Fail
. 2024 Oct;
17(11):e012067.
PMID: 39435559
Background: Pulmonary arterial hypertension (PAH) is a disease of progressive right ventricular (RV) failure with high morbidity and mortality. Our goal is to investigate proteomic features and pathways associated with...
4.
Rayner S, Tedford R, Leary P, Mak S, Houston B
Am J Respir Crit Care Med
. 2024 Apr;
210(6):712-714.
PMID: 38668713
No abstract available.
5.
Oppegard L, Barros L, Pi H, Kornfield J, Hough C, Rayner S, et al.
Pulm Circ
. 2023 Nov;
13(4):e12308.
PMID: 38027456
Relationships between obesity and outcomes in pulmonary arterial hypertension (PAH) are complex. Previous work suggested obesity, occurring alongside PAH, may be associated with better survival. In our work, we suggest...
6.
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension due to septic emboli
Steinberg Z, Rayner S, Leary P
Catheter Cardiovasc Interv
. 2023 Nov;
103(1):115-118.
PMID: 37994384
We present the case of a 28-year-old woman with a history of tricuspid valve endocarditis leading to chronic thromboembolic pulmonary hypertension (CTEPH) with multiple pulmonary artery chronic total occlusions (CTOs)...
7.
Michailidou D, Chen D, Collins B, George M, Montani D, Rayner S, et al.
Am J Respir Crit Care Med
. 2023 Jun;
208(5):e29-e31.
PMID: 37311250
No abstract available.
8.
Rayner S, Hung C, Liles W, Altemeier W
Am J Physiol Lung Cell Mol Physiol
. 2023 May;
325(1):L1-L8.
PMID: 37130806
Pericytes are microvascular mural cells that directly contact endothelial cells. They have long been recognized for their roles in vascular development and homeostasis, but more recently have been identified as...
9.
Carlozzi L, Lee J, Barros L, Buber Y, Chen D, Mulligan M, et al.
Respir Med
. 2023 Mar;
211:107215.
PMID: 36934856
Introduction: Balloon pulmonary angioplasty (BPA) is a less invasive treatment alternative for patients with chronic thromboembolic pulmonary hypertension (CTEPH) who are unable to move forward with pulmonary thromboendarterectomy. This report...
10.
Pi H, Xia L, Ralph D, Rayner S, Shojaie A, Leary P, et al.
Circ Res
. 2023 Jan;
132(3):254-266.
PMID: 36597887
Background: Pulmonary arterial hypertension (PAH) is a complex disease characterized by progressive right ventricular (RV) failure leading to significant morbidity and mortality. Investigating metabolic features and pathways associated with RV...